Press Releases

09.13.2013

Gliknik Enters Into Licensing Agreement With Pfizer For Drug Candidate Targeting Autoimmune Diseases

06.06.2013

CytomX Announces Global Strategic Collaboration with Pfizer to Develop and Commercialize Multiple Probody™-Drug Conjugates in Oncology

04.03.2013

BIND Therapeutics Announces Global Collaboration with Pfizer to Develop and Commercialize Multiple Accurins

01.03.2013

Philogen S.p.A. Announces Worldwide Licensing Agreement with Pfizer Inc. for Dekavil, an Investigational Immunoregulatory Therapy for Autoimmune Diseases

01.03.2013

Repligen Announces Licensing Agreement with Pfizer for Spinal Muscular Atrophy Program

12.21.2012

Halozyme Therapeutics And Pfizer Enter Into A Collaboration To Develop And Commercialize Subcutaneous Biologics Using Recombinant Human Hyaluronidase

12.20.2012

Humedica and Pfizer Form Strategic Alliance

11.30.2012

Pfizer Completes Sale of Nutrition Business to Nestlé

11.28.2012

Pfizer Acquires NextWave Pharmaceuticals, Inc.

11.19.2012

Cystic Fibrosis Foundation Therapeutics Announces $58 Million CF Drug Discovery Agreement with Pfizer

09.12.2012

Pfizer And Hisun Announce Launch Of Hisun-Pfizer Pharmaceuticals Co., Ltd.

08.31.2012

VLST Corporation Announces In-licensing Agreement with Pfizer for Anti-CD40 Monoclonal Antibody